Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Doctors and patients have different thresholds for acceptance of
the risks of increased bleeding with antithrombotic drugs used to
prevent stroke in atrial fibrillation. Previous observational studies
have shown that antithrombotic drugs are underprescribed by doctors.
Devereaux and colleagues (p 1218) studied the thresholds for risk of
stroke and bleeding. Patients placed significantly more value on
the avoidance of stroke and less value on the avoidance of bleeding
than did doctors. Doctors showed little consistency as to how much risk
of bleeding was acceptable. Patients' preferences should be
incorporated into the decision to use these drugs in people with atrial fibrillation.
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.